Oklahoma Medical Research Foundation; MS Center of Excellence
				
				
					825 Northeast 13th Street					
Oklahoma City, Oklahoma 73104
														
          Oklahoma City, Oklahoma 73104
We've found
        4 trials
        at this facility
      	
	Multiple Sclerosis Clinical Trial
	
Updated: 5/8/2017
  
  
  Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 5/8/2017
Click here to add this to my saved trials
	    
	 
  	
	Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Multiple Sclerosis Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Multiple Sclerosis (MS) Clinical Trial
	
Updated: 12/31/1969
  
  
  Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	